Fluoroquinolone-resistant Salmonella Paratyphi A.
作者信息
Adachi Takuya, Sagara Hiroko, Hirose Kenji, Watanabe Haruo
出版信息
Emerg Infect Dis. 2005 Jan;11(1):172-4. doi: 10.3201/eid1101.040145.
Abstract
摘要
相似文献
1
Fluoroquinolone-resistant Salmonella Paratyphi A.
Emerg Infect Dis. 2005 Jan;11(1):172-4. doi: 10.3201/eid1101.040145.
2
Suboptimal clinical response to ciprofloxacin in patients with enteric fever due to Salmonella spp. with reduced fluoroquinolone susceptibility: a case series.
BMC Infect Dis. 2004 Sep 20;4:36. doi: 10.1186/1471-2334-4-36.
3
Drug-resistant Salmonella enterica serotype paratyphi A in India.
Emerg Infect Dis. 2000 Jul-Aug;6(4):420-1. doi: 10.3201/eid0604.000420.
4
A need to revise ciprofloxacin breakpoints for Salmonella in human beings.
Int J Infect Dis. 2008 Nov;12(6):e143-4. doi: 10.1016/j.ijid.2008.03.004. Epub 2008 May 29.
5
Molecular characterization of ciprofloxacin-resistant Salmonella enterica serovar Typhi and Paratyphi A causing enteric fever in India.
J Antimicrob Chemother. 2006 Dec;58(6):1139-44. doi: 10.1093/jac/dkl391. Epub 2006 Oct 28.
6
Isolated high-level ciprofloxacin resistance in Salmonella enterica subsp. enterica serotype Paratyphi A.
J Med Microbiol. 2004 Aug;53(Pt 8):819. doi: 10.1099/jmm.0.05451-0.
7
Fluoroquinolone resistance in Salmonella typhi and S. paratyphi A in Bangalore, India.
Trans R Soc Trop Med Hyg. 2007 Mar;101(3):308-10. doi: 10.1016/j.trstmh.2006.05.009. Epub 2006 Sep 6.
8
Fluoroquinolone resistance among Salmonella enterica serovar Paratyphi A in Pondicherry.
Indian J Med Res. 2006 Nov;124(5):585-7.
9
Identifying the mechanism underlying treatment failure for Salmonella Paratyphi A infection using next-generation sequencing - a case report.
BMC Infect Dis. 2019 Feb 26;19(1):191. doi: 10.1186/s12879-019-3821-x.
10
Ciprofloxacin resistance in Salmonella paratyphi A.
J Antimicrob Chemother. 1994 Jun;33(6):1258-9. doi: 10.1093/jac/33.6.1258.
引用本文的文献
1
Paratyphoid fever and the genomics of Salmonella enterica serovar Paratyphi A in Taiwan.
PLoS Negl Trop Dis. 2025 Sep 11;19(9):e0013048. doi: 10.1371/journal.pntd.0013048. eCollection 2025 Sep.
2
Mutational Diversity in the Quinolone Resistance-Determining Regions of Type-II Topoisomerases of Serovars.
Antibiotics (Basel). 2021 Nov 26;10(12):1455. doi: 10.3390/antibiotics10121455.
3
Genomic surveillance detects Salmonella enterica serovar Paratyphi A harbouring blaCTX-M-15 from a traveller returning from Bangladesh.
PLoS One. 2020 Jan 30;15(1):e0228250. doi: 10.1371/journal.pone.0228250. eCollection 2020.
4
Epidemiology, Clinical Presentation, Laboratory Diagnosis, Antimicrobial Resistance, and Antimicrobial Management of Invasive Salmonella Infections.
Clin Microbiol Rev. 2015 Oct;28(4):901-37. doi: 10.1128/CMR.00002-15.
5
Increasing antimicrobial resistance and narrowing therapeutics in typhoidal salmonellae.
J Clin Diagn Res. 2013 Mar;7(3):576-9. doi: 10.7860/JCDR/2013/4765.2831. Epub 2013 Mar 1.
6
Fluoroquinolones for treating typhoid and paratyphoid fever (enteric fever).
Cochrane Database Syst Rev. 2011 Oct 5;2011(10):CD004530. doi: 10.1002/14651858.CD004530.pub4.
7
Quinolone and cephalosporin resistance in enteric Fever.
J Glob Infect Dis. 2010 Sep;2(3):258-62. doi: 10.4103/0974-777X.68529.
8
In vitro synergism of ciprofloxacin and cefotaxime against nalidixic acid-resistant Salmonella enterica serotypes Paratyphi A and Paratyphi B.
Antimicrob Agents Chemother. 2010 Sep;54(9):3696-701. doi: 10.1128/AAC.00988-09. Epub 2010 Jun 21.
9
A multiplex single nucleotide polymorphism typing assay for detecting mutations that result in decreased fluoroquinolone susceptibility in Salmonella enterica serovars Typhi and Paratyphi A.
J Antimicrob Chemother. 2010 Aug;65(8):1631-41. doi: 10.1093/jac/dkq175. Epub 2010 May 28.
10
Translational genomics to develop a Salmonella enterica serovar Paratyphi A multiplex polymerase chain reaction assay.
J Mol Diagn. 2007 Nov;9(5):624-30. doi: 10.2353/jmoldx.2007.070064.
本文引用的文献
1
DNA sequence analysis of DNA gyrase and DNA topoisomerase IV quinolone resistance-determining regions of Salmonella enterica serovar Typhi and serovar Paratyphi A.
Antimicrob Agents Chemother. 2002 Oct;46(10):3249-52. doi: 10.1128/AAC.46.10.3249-3252.2002.
2
Detection of decreased in vitro susceptibility to ciprofloxacin in Salmonella enterica serotypes Typhi and Paratyphi A.
J Antimicrob Chemother. 2001 Nov;48(5):740-1. doi: 10.1093/jac/48.5.740.
3
Drug-resistant Salmonella enterica serotype paratyphi A in India.
Emerg Infect Dis. 2000 Jul-Aug;6(4):420-1. doi: 10.3201/eid0604.000420.
4
Comparative studies of mutations in animal isolates and experimental in vitro- and in vivo-selected mutants of Salmonella spp. suggest a counterselection of highly fluoroquinolone-resistant strains in the field.
Antimicrob Agents Chemother. 1999 Sep;43(9):2131-7. doi: 10.1128/AAC.43.9.2131.
5
Epidemic ciprofloxacin-resistant Salmonella typhi in Tajikistan.
Lancet. 1998 Jan 31;351(9099):339. doi: 10.1016/s0140-6736(05)78338-0.
6
Emerging drug resistance and vaccination for typhoid fever.
JAMA. 1998 Feb 25;279(8):579; author reply 580.
7
Quinolone-resistant Salmonella typhi in Viet Nam: molecular basis of resistance and clinical response to treatment.
Clin Infect Dis. 1997 Dec;25(6):1404-10. doi: 10.1086/516128.
8
Mutations responsible for reduced susceptibility to 4-quinolones in clinical isolates of multi-resistant Salmonella typhi in India.
J Antimicrob Chemother. 1996 May;37(5):891-900. doi: 10.1093/jac/37.5.891.
9
High-level fluoroquinolone resistance in a Salmonella typhimurium isolate due to alterations in both gyrA and gyrB genes.
J Antimicrob Chemother. 1993 Sep;32(3):367-77. doi: 10.1093/jac/32.3.367.
10
Spread of multiresistant Salmonella typhi.
Lancet. 1990 Oct 27;336(8722):1065-6.
Zotero 插件